Skip to main content
Clinical Trials/NCT03529656
NCT03529656CompletedNot Applicable

The Safety and Efficacy of Early Rehabilitation Program in Immediate Liver Transplant Patients

Asan Medical Center0 sites236 target enrollmentStarted: October 1, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
236
Primary Endpoint
ICU day (days)

Study Overview

Brief Summary

The purpose of this study is to determine whether an early rehabilitation program for immediate liver transplant patients is safe and effective in preventing critical care illness and intensive care unit acquired weakness.

Detailed Description

Patients with liver transplantation (LT) have poor general condition before surgery and require ICU care for a certain period. For those patients, the side effects of ICU care such as intensive care unit-acquired weakness (ICU-AW), critical illness polyneuropathy (CIP) are well known. Therefore, we access the safety and efficacy of early rehabilitation program (ERP) in liver transplant recipients.

Patients were retrospectively selected for the Pre-ERP group (2014.05-2014.10) and for the Post-ERP group (2015.10-2016.03). During the period of 6 months, 136 patients and 100 patients underwent LT, and 65, 62 patients were enrolled after exclusion. Forty patients from the each group were compared after propensity score matching (PSM).

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • immediate post liver transplant patients

Exclusion Criteria

  • patients who transferred to sub-ICU within 72 hours re-liver transplantation case wound, mental problem post op bleeding unstable vital

Outcomes

Primary Outcomes

ICU day (days)

Time Frame: up to 60 days

ventilator day (days)

Time Frame: up to 60 days

Secondary Outcomes

  • hospital readmission rate after surgery (%)(1 year follow up from the surgery)
  • 1 year mortality rate (%)(1 year follow up from the surgery)
  • Time to start rehabilitation from ICU admission (days)(up to 2 weeks)
  • in-hospital LOS (days)(up to 24 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Suk-Kyung

Associate professor

Asan Medical Center

Similar Trials